EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 359 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,244,335 | +12.6% | 56,949 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $1,105,341 | -6.1% | 57,841 | -4.6% | 0.00% | 0.0% |
| Q1 2023 | $1,177,157 | +15.2% | 60,647 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $1,021,812 | -13.7% | 63,704 | -15.6% | 0.00% | 0.0% |
| Q3 2022 | $1,184,000 | -23.9% | 75,522 | +1.1% | 0.00% | -33.3% |
| Q2 2022 | $1,556,000 | -16.2% | 74,736 | -8.7% | 0.00% | 0.0% |
| Q1 2022 | $1,856,000 | +43.2% | 81,866 | +15.5% | 0.00% | +50.0% |
| Q4 2021 | $1,296,000 | -14.0% | 70,897 | -0.5% | 0.00% | -33.3% |
| Q3 2021 | $1,507,000 | +71.6% | 71,289 | +47.9% | 0.00% | +50.0% |
| Q2 2021 | $878,000 | -4.9% | 48,208 | +17.9% | 0.00% | 0.0% |
| Q1 2021 | $923,000 | +47.2% | 40,875 | +30.8% | 0.00% | +100.0% |
| Q4 2020 | $627,000 | -14.8% | 31,253 | +3.7% | 0.00% | -50.0% |
| Q3 2020 | $736,000 | +1.8% | 30,138 | -1.1% | 0.00% | 0.0% |
| Q2 2020 | $723,000 | +34.1% | 30,459 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $539,000 | +57.1% | 31,347 | +61.2% | 0.00% | +100.0% |
| Q4 2019 | $343,000 | -11.4% | 19,444 | -11.3% | 0.00% | 0.0% |
| Q3 2019 | $387,000 | -34.2% | 21,926 | -20.3% | 0.00% | -50.0% |
| Q2 2019 | $588,000 | -37.1% | 27,500 | -30.0% | 0.00% | -33.3% |
| Q1 2019 | $935,000 | +212.7% | 39,267 | +158.8% | 0.00% | +200.0% |
| Q4 2018 | $299,000 | +686.8% | 15,170 | +600.0% | 0.00% | – |
| Q3 2018 | $38,000 | +1800.0% | 2,167 | +2067.0% | 0.00% | – |
| Q2 2018 | $2,000 | -96.8% | 100 | -96.5% | 0.00% | – |
| Q1 2018 | $63,000 | -38.2% | 2,831 | -15.5% | 0.00% | – |
| Q4 2017 | $102,000 | +30.8% | 3,350 | +3.7% | 0.00% | – |
| Q3 2017 | $78,000 | +3800.0% | 3,232 | +3132.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 100 | -68.4% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 316 | +216.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
| Q3 2014 | $2,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | -60.0% | 1,100 | -31.2% | 0.00% | – |
| Q4 2013 | $10,000 | +11.1% | 1,600 | +6.7% | 0.00% | – |
| Q3 2013 | $9,000 | +28.6% | 1,500 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |